ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

No Link Between Pneumonitis, Taxanes, And Radiation

November 26, 2004

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

March 11, 1977

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994